The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Remember how, last week, we talked about tech giant Microsoft (MSFT) and its plans to get AI involved in medicine? Well, ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.